These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 18192473)
1. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study. Yu SC; Hui EP; Wong J; Wong H; Mo F; Ho SS; Wong YY; Yeo W; Lai PB; Chan AT; Mok TS J Vasc Interv Radiol; 2008 Jan; 19(1):95-103. PubMed ID: 18192473 [TBL] [Abstract][Full Text] [Related]
2. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization. Yu SC; Hui JW; Hui EP; Mo F; Lee PS; Wong J; Lee KF; Lai PB; Yeo W J Vasc Interv Radiol; 2009 Mar; 20(3):352-9. PubMed ID: 19167240 [TBL] [Abstract][Full Text] [Related]
3. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session]. El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077 [TBL] [Abstract][Full Text] [Related]
4. Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture. Gu YK; Luo RG; Huang JH; Si Tu QJ; Li XX; Gao F World J Gastroenterol; 2010 Dec; 16(45):5766-72. PubMed ID: 21128329 [TBL] [Abstract][Full Text] [Related]
5. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y; Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [TBL] [Abstract][Full Text] [Related]
6. Mechanism and Natural Course of Tumor Involution in Hepatocellular Carcinoma Following Transarterial Ethanol Ablation. Yu SC; Lau TW; Tang P; Chan SK; Chu CC; Hui JW; Lee KF; Chan A Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1136-43. PubMed ID: 27154017 [TBL] [Abstract][Full Text] [Related]
7. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization. Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146 [TBL] [Abstract][Full Text] [Related]
8. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716 [TBL] [Abstract][Full Text] [Related]
9. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma. Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001 [TBL] [Abstract][Full Text] [Related]
10. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma]. Chen M; Li J; Zhang Y Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027 [TBL] [Abstract][Full Text] [Related]
11. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777 [TBL] [Abstract][Full Text] [Related]
12. Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization. Yu SC; Hui JW; Hui EP; Chan SL; Lee KF; Mo F; Wong J; Ma B; Lai P; Mok T; Yeo W Radiology; 2014 Feb; 270(2):607-20. PubMed ID: 24126369 [TBL] [Abstract][Full Text] [Related]
13. Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes. Yu SC; Hui EP; Tang P; Chan SK; Chu CC; Hui JW; Chan SL; Lee KF; Lai PB; Yeo W J Vasc Interv Radiol; 2016 May; 27(5):639-49. PubMed ID: 26803574 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea. Ikeda M; Arai Y; Park SJ; Takeuchi Y; Anai H; Kim JK; Inaba Y; Aramaki T; Kwon SH; Yamamoto S; Okusaka T; ; J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316 [TBL] [Abstract][Full Text] [Related]